The price of Sotera Health Company (NASDAQ:SHC) shares last traded on Wall Street fell -4.87% to $17.58.
Based on available information, 7 analysts follow Sotera Health Company (NASDAQ:SHC). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $23.00 and a low of $16.00, we find $18.00. Given the previous closing price of $18.48, this indicates a potential downside of -2.6 percent. SHC stock price is now 3.72% away from the 50-day moving average and 23.90% away from the 200-day moving average. The market capitalization of the company currently stands at $4.99B.
Among analysts, 3 rate the stock a hold while 3 rate it a buy. Brokers who have rated the stock have averaged $19.14 as their price target over the next twelve months.
With the price target maintained at $24, KeyBanc Capital Markets recently Upgraded its rating from Sector Weight to Overweight for Sotera Health Company (NASDAQ: SHC).
Insiders disposed of 53,951 shares of company stock worth roughly $0.95 million over the past 1 year. A total of 0.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SHC stock. A new stake in Sotera Health Company shares was purchased by HAWK RIDGE CAPITAL MANAGEMENT LP during the first quarter worth $32,409,000. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC invested $31,218,000 in shares of SHC during the first quarter. In the first quarter, MASSACHUSETTS FINANCIAL SERVICES CO /MA/ acquired a new stake in Sotera Health Company valued at approximately $17,692,000. FIRST TRUST ADVISORS LP acquired a new stake in SHC for approximately $14,121,000. MAGNETAR FINANCIAL LLC purchased a new stake in SHC valued at around $7,839,000 in the second quarter. In total, there are 254 active investors with 88.20% ownership of the company’s stock.
A candlestick chart of Sotera Health Company (NASDAQ: SHC) showed a price of $17.00 on Thursday morning. During the past 12 months, Sotera Health Company has had a low of $5.78 and a high of $20.41. As of last week, the company has a debt-to-equity ratio of 6.36, a current ratio of 1.50, and a quick ratio of 1.50. The fifty day moving average price for SHC is $17.01 and a two-hundred day moving average price translates $14.24 for the stock.
The latest earnings results from Sotera Health Company (NASDAQ: SHC) was released for Mar, 2023. According to the Diagnostics & Research Company, earnings per share came in at $0.13, missing analysts’ expectations of $0.14 by -0.01. This compares to $0.11 EPS in the same period last year. The company reported revenue of $220.59 million for the quarter, compared to $236.75 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -6.83 percent. For the current quarter, analysts expect SHC to generate $258.93M in revenue.
Sotera Health Company(SHC) Company Profile
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company’s sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services. The company serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
